Article
Genetics of Pancreatic Neuroendocrine Tumors.
Hematology/oncology clinics of North America - 1 Oct 2022
Mohindroo Chirayu, McAllister Florencia, De Jesus-Acosta Ana
Abstract excerpt
Pancreatic neuroendocrine tumors (pNETs) represent a relatively rare disease; however, the incidence has been increasing during the last 2 decades. Next generation sequencing has greatly increased our understanding of driver mutations in pNETs. Sporadic pNETs have consistently presented with mutations in MEN1, DAXX/ATRX, and genes related to the mammalian target of rapamycin pathway. Inherited pNETs have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
